Atlantic Investment Company’s AbbVie ABBV Stock Holding History

Atlantic Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$251K	Buy	4,619 +90	+2%	+$5.86K	0.73%	40
2015 Q2	$304K	Sell	4,529 -290	-6%	-$18.9K	0.73%	41
2015 Q1	$282K	Buy	4,819 +115	+2%	+$6.95K	0.55%	43
2014 Q4	$308K	Buy	+4,704	New	+$297K	0.43%	42
2014 Q3	–	Sell	-4,459	Closed	-$248K	–	47
2014 Q2	$252K	Hold	4,459	–	–	0.22%	47
2014 Q1	$229K	Hold	4,459	–	–	0.22%	48
2013 Q4	$235K	Buy	+4,459	New	+$219K	0.21%	48

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Atlantic Investment Company's ABBV Position: Q3 2015 in Review

Atlantic Investment Company increased its AbbVie (ABBV) stake by 2% in Q3 2015, buying an estimated $5.86K and bringing the position to 4,619 shares worth $251K. The position accounts for 0.73% of the portfolio, ranked #40.

Atlantic Investment Company first reported a position in ABBV in Q4 2013 and has held it in 7 quarters since. The position peaked at $308K in Q4 2014. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Atlantic Investment Company held 4,619 shares of AbbVie worth $251K as of Q3 2015.
Atlantic Investment Company bought 90 AbbVie shares in Q3 2015, an estimated $5.86K.
AbbVie made up 0.73% of Atlantic Investment Company's portfolio in Q3 2015, its #40 holding.
Atlantic Investment Company first reported a position in AbbVie in Q4 2013 and has held it in 7 quarters since.
Atlantic Investment Company's AbbVie position peaked at $308K in Q4 2014.
1,604 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Atlantic Investment Company's 13F filing for Q3 2015, filed 13 Nov 2015.